Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
about
NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen SpeciesAdverse drug reactions and drug-drug interactions with over-the-counter NSAIDsDisease risk score as a confounder summary method: systematic review and recommendationsChemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancerThe Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review ArticleRapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapyAn economic model of long-term use of celecoxib in patients with osteoarthritisDesign of group IIA secreted/synovial phospholipase A(2) inhibitors: an oxadiazolone derivative suppresses chondrocyte prostaglandin E(2) secretionAnti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema.Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham heart study.An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease.A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment.Comparative Effectiveness Research Using Observational Data: Active Comparators to Emulate Target Trials with Inactive Comparators.The effectiveness of pulsed electrical stimulation (E-PES) in the management of osteoarthritis of the knee: a protocol for a randomised controlled trial.Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran communitySubgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative dataRisk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current eviAll-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: a longitudinal study.Therapeutic effect of irradiation of magnetic infrared laser on osteoarthritis rat model.Increased Risk of Coronary Heart Disease in Patients with Primary Fibromyalgia and Those with Concomitant Comorbidity-A Taiwanese Population-Based Cohort StudyNon-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials.Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes.Chondroprotective and anti-inflammatory effects of ChondroT, a new complex herbal medicationEffects of expanding the look-back period to all available data in the assessment of covariates.Selective COX-2 inhibitors, NSAIDs and cardiovascular events - is celecoxib the safest choice?Cardiovascular co-morbidity in rheumatic diseases.Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe?Inflammation in Depression and the Potential for Anti-Inflammatory TreatmentThe association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults.Inhibition of phorbol ester-induced mouse skin tumor promotion and COX-2 expression by celecoxib: C/EBP as a potential molecular target.Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.Sex differences in innate immunity and its impact on opioid pharmacology.Risk of stroke associated with nonsteroidal anti-inflammatory drugsCelecoxib in arthritis: relative risk management profile and implications for patients.Stroke risk and NSAIDs: a systematic review of observational studies.Comparative risks of non-prescription analgesics: a structured topic review and research priorities.Cardiovascular risk in juvenile idiopathic arthritis.Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies.Defining a reference set to support methodological research in drug safety.
P2860
Q26784322-AABABE78-B733-4309-A7B3-F8A38A230D39Q26800279-653F4E6E-981C-443E-B10C-4CEF4E8709F6Q26999267-D2CD9954-FBBD-4A84-960E-8FD4A28563A0Q27026428-95D524F3-27E1-459B-BA22-BFD233F678EEQ28075382-D74E7E6D-AD5F-498E-9E4F-9D64914D8FC9Q28213719-ADB0818F-8DE2-448A-AF2D-4299C201C1E6Q28218005-D812D824-46EE-4B1F-8603-694B103156EEQ28474126-18B18BFA-9039-46F9-8A60-5E8A087B21C4Q29346992-01FB3CF1-051D-471F-B3B8-E73F6FDEE3E1Q30667639-452C391B-86E7-4257-98D4-8B3BFC0797F3Q30696956-297689D9-4E36-4D67-AF4D-BB89CF618906Q30812957-5EACA546-15E9-40D2-B993-A93CDE0ADCE0Q31144980-AF700163-62A9-4B18-B95A-432D757228CDQ33317819-E288E7A8-2722-4DEF-BFA7-983A38FB93FAQ33906348-20DD6AE5-3E5D-42B1-85A3-739BA0B57380Q33908100-32647725-E941-4047-981D-CEA8CAC944B1Q34133867-9AE9B4F3-04FD-4116-9903-FB1AE430B223Q34148370-316EE318-7255-4956-AD3A-763A114A8CE0Q34996960-0556CCF1-41F7-45E8-8552-EDC64E1A5BD8Q35194430-D15B58DA-F407-4D23-8ABF-8556333E4452Q35772504-050C3DE7-7E10-46D4-B0F8-E7814E9D5DFDQ36013803-4E061AC8-5BC4-442C-9ACB-1AC540554C5CQ36023793-986A96C7-8944-44A4-ADED-793429FA9619Q36076502-93FA094F-3F0C-42B4-BD4B-80086B600B3CQ36342865-D71B29A6-49F6-48AC-8B50-EC2C588D1D78Q36645806-2ED068A9-0B45-4CAE-8EEC-DA8DC0EA6373Q36835851-EECEFB99-E0E0-438A-A746-405AF0ACA615Q36869571-57D268F0-0BD0-49D9-B3A5-FBE5B22B3867Q37310528-22059679-E7DF-434C-AB1D-15219B34B9A1Q37329089-FEAF2542-A7CD-4C0B-B413-59C00758AAC0Q37341749-E239C7B1-E994-4E24-B2EC-DBC0473F6D40Q37422931-353AE783-18DA-47FF-BC88-40D89E0C6068Q37432134-3A27BAED-C534-42B2-A978-4EBB9F68F227Q37464386-58671E9B-7FCA-4183-A301-682B3C59C758Q37643458-C9C92D5F-CBA5-4EA4-989F-CE933A74D4FBQ37942486-003BE288-8DE0-4EDE-A30A-0A7CA059479FQ37947341-46FECCA9-3953-4204-BF29-45BF899CC19EQ38090373-DE99A358-6226-48ED-8C1C-6724D2307363Q38101544-203E08A3-82D8-4741-B829-8D327E83347EQ38156066-0BE1EAEA-C33E-49A3-8AA2-CAE44AA0700C
P2860
Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cardiovascular outcomes in new ...... roups and time course of risk.
@ast
Cardiovascular outcomes in new ...... roups and time course of risk.
@en
Cardiovascular outcomes in new ...... roups and time course of risk.
@nl
type
label
Cardiovascular outcomes in new ...... roups and time course of risk.
@ast
Cardiovascular outcomes in new ...... roups and time course of risk.
@en
Cardiovascular outcomes in new ...... roups and time course of risk.
@nl
prefLabel
Cardiovascular outcomes in new ...... roups and time course of risk.
@ast
Cardiovascular outcomes in new ...... roups and time course of risk.
@en
Cardiovascular outcomes in new ...... roups and time course of risk.
@nl
P2093
P356
P1476
Cardiovascular outcomes in new ...... roups and time course of risk.
@en
P2093
Daniel H Solomon
Helen Mogun
Jerry Avorn
Robert J Glynn
Sebastian Schneeweiss
P304
P356
10.1002/ART.21887
P50
P577
2006-05-01T00:00:00Z